Tectonic Therapeutic (TECX) Change in Accured Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Change in Accured Expenses data on file, last reported at $1.6 million in Q1 2026.

• On a quarterly basis, Change in Accured Expenses rose 147.79% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a 143.08% increase from a year earlier, with the FY2025 full-year figure at -$552000.0, up 90.22% from the prior year.
• Change in Accured Expenses for Q1 2026 stood at $1.6 million, up from $571000.0 in the prior quarter.
• Over the last five years, Change in Accured Expenses for TECX reached as high as $2.3 million in Q2 2023 and fell as low as -$3.4 million in Q1 2025.
• Historically, Change in Accured Expenses has averaged -$403294.1 across 5 years, with a median of -$261000.0 in 2022.
• Across the five-year window, Change in Accured Expenses jumped 979.69% in 2023 and sank 347.25% in 2025, its largest moves.
• Year by year, Change in Accured Expenses stood at -$2.6 million in 2022, then jumped by 171.13% to $1.8 million in 2023, then slumped by 272.49% to -$3.2 million in 2024, then jumped by 117.89% to $571000.0 in 2025, then surged by 185.99% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Change in Accured Expenses figures were $1.6 million in Q1 2026, $571000.0 in Q4 2025, and $34000.0 in Q3 2025.